Filing Details

Accession Number:
0001415889-23-014586
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-10-30 14:01:17
Reporting Period:
2023-10-26
Accepted Time:
2023-10-30 14:01:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597264 Blueprint Medicines Corp BPMC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1718648 K. Christopher Murray C/O Blueprint Medicines Corporation
45 Sidney Street
Cambridge MA 02139
Chief Technical Operations No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-10-26 600 $56.40 25,095 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Effected pursuant to a trading plan adopted on June 5, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.